LabMD, Inc. v. Federal Trade Commission

678 F. App'x 816
CourtCourt of Appeals for the Eleventh Circuit
DecidedNovember 10, 2016
DocketNo. 16-16270-D
StatusPublished
Cited by7 cases

This text of 678 F. App'x 816 (LabMD, Inc. v. Federal Trade Commission) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
LabMD, Inc. v. Federal Trade Commission, 678 F. App'x 816 (11th Cir. 2016).

Opinion

BY THE COURT:

LabMD’s “Time Sensitive Motion to Stay Enforcement of the Commission’s Final Order Pending Appeal, and for a Temporary Stay While the Court Considers the Motion” is GRANTED.

[818]*818I.

LabMD operated as a clinical laboratory from 2001 through early 2014. It received specimen samples for testing and reported the results to patients’ physicians. As part of its business, LabMD received sensitive personal information for over 750,000 patients, which included their names, birthdates, addresses, and Social Security numbers, as well as certain medical and insurance information.

In 2005, LabMD’s billing manager downloaded and installed a peer-to-peer file-sharing program called LimeWire on her work computer. She did this so she could download music and video files for her personal use. Unfortunately, Lime-Wire allows other users to search for and download any file that is available for sharing on a computer connected to the file-sharing program. The billing manager designated her “My Documents” folder on her computer as a folder from which files could be searched and downloaded. At the same time a file designated the “1718 file,” which contained 1,718 pages of sensitive personal information for roughly 9,300 patients, including their names, birthdates, and Social Security numbers, was also in the billing manager’s ■ “My Documents” folder that was accessible through Lime-Wire.

In 2008, Tiversa Holding Company (“Tiversa”), a data security company, notified LabMD that it had a copy of the 1718 file. Tiversa employed forensic analysts to search peer-to-peer networks specifically for files that were likely to contain sensitive personal information in an effort to “monetize” those files through targeted sales of Tiversa’a data security services to companies it was able to infiltrate. Tiversa tried to get LabMD’s business in this way. Tiversa repeatedly asked LabMD to buy its breach detection services, and falsely claimed that copies of the 1718 file were being searched for and downloaded on peer-to-peer networks.

After LabMD declined to purchase Tiv-ersa’s services, Tiversa informed the Federal Trade Commission (“FTC”) that LabMD and other companies had been subject to data breaches involving its customers’ personal information in 2009. Tiv-ersa’s CEO instructed one of his employees to “make sure [LabMD is] at the top of the list” of companies that had suffered a security breach that was given to the FTC. Notably, Tiversa did not include any of its own current or former clients on the list. Tiversa hoped that the FTC would contact the companies on its list of those subject to security breaches, so those companies would feel pressured to purchase Tiversa’s services out of fear of an FTC enforcement action.

As a result of the information provided by Tiversa, the FTC launched an investigation into LabMD’s data security practices in 2010. Despite the dissent of at least one commissioner, the FTC relied on the information provided by Tiversa, including the false assertion that at least four different Internet Protocol addresses had downloaded the 1718 file from peer-to-peer networks. The FTC voted to issue a complaint against LabMD in 2013, The FTC alleged that LabMD failed to provide reasonable and appropriate security for its customers’ personal information and that this failure caused (or was likely to cause) substantial consumer injury, constituting an unfair act in violation of the Federal Trade Commission Act, 15 U.S.C. § 45. This complaint resulted in an Administrative Law Judge (“AL J”) holding an eviden-tiary hearing beginning in May 2014, which concluded in July 2015. After hearing the parties’ evidence, the ALJ dismissed the complaint, finding a failure of proof that LabMD’s computer data security practices “caused” or were “likely to [819]*819cause” substantial consumer injury. The ALJ found that because there was no proof anyone other than Tiversa had downloaded the 1718 file, it was unlikely that the information in that file was the source of any harm now or would be in the future. The ALJ also rejected the argument that a hypothetical risk of future harm was a sufficient basis for holding that the breach was likely to cause future harm.

This ruling was appealed to the FTC. The FTC reversed, holding that the ALJ applied the wrong standard in deciding whether LabMD’s data security practices were unreasonable and therefore constituted an unfair act in violation of the FTC Act. The FTC vacated the ALJ’s ruling and issued a Final Order requiring LabMD to implement a number of compliance measures, including creating a comprehensive information security program; undergoing professional routine assessments of that program; providing notice to any possible affected individual and health insurance company; and setting up a toll-free hotline for any affected individual to call.

LabMD ceased operations in January 2014. LabMD says its business could not bear the costs imposed by the FTC investigation and litigation, so it had to close. LabMD has essentially no assets, no revenue, and does not plan to resume business in the future. It obtained counsel pro bono because it could not afford to pay a lawyer. LabMD now has no employees, and keeps only the records required by law in a secured room, on an unplugged computer that is not connected to the Internet. LabMD has less than $5,000 cash on hand, and is subject to a $1 million judgment for terminating its lease early..

II.

LabMD decided to appeal the FTC’s Final Order to this Court, and sought a stay from the FTC pending our review. The FTC denied the stay, and LabMD now asks us to grant the stay.

The “traditional” standard for a stay pending appeal balances four factors: “(1) whether the stay applicant has made a strong showing that he is likely to succeed on the merits; (2) whether the applicant will be irreparably injured absent a stay; (3) whether issuance of the stay will substantially injure the other parties interested in the proceeding; and (4) where the public interest lies.” Nken v. Holder, 556 U.S. 418, 425-26, 129 S.Ct. 1749, 1756, 173 L.Ed.2d 550 (2009) (quotation omitted). “The first two factors ... are the most critical.” Id. at 434, 129 S.Ct. at 1761. But a motion can still be “granted upon a lesser showing of a substantial case on the merits when the balance of the equities identified in factors 2, 3, and 4 weighs heavily in favor of granting the stay.” Garcia-Mir v. Meese, 781 F.2d 1450, 1453 (11th Cir. 1986) (quotation omitted and alteration adopted). We have also “emphasized” that granting a stay that simply maintains the status quo pending appeal “is appropriate when a serious legal question is presented, when little if any harm will befall other interested persons or the public and when denial of the [stay] would inflict irreparable injury on the movant.” Ruiz v. Estelle, 650 F.2d 555, 565 (5th Cir. 1981) (per curiam) (quotation omitted).1 LabMD has made this showing.

A.

This case turns on whether the FTC’s interpretation of § 45(n) is reason[820]*820able. The FTG Act declares that “[ujnfair methods of competition ...

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
678 F. App'x 816, Counsel Stack Legal Research, https://law.counselstack.com/opinion/labmd-inc-v-federal-trade-commission-ca11-2016.